People · Operator
Named in public records as an officer, director or promoter · active 2023–2026 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neonc Technologies Holdings, Inc. | — | Biotechnology | Series C | $121.6M | $51.9M | 2023 |
KEITHLY C GARNETT at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside KEITHLY C GARNETT on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven C Giannotta | 1 | 1 |
| Victoria C Medvec | 1 | 1 |
| Ming-Fu (Alan) C Chiang | 1 | 1 |
| AMIR C HESHMATPOUR | 1 | 1 |
| THOMAS C CHEN | 1 | 1 |
| Jim C Delshad | 1 | 1 |
| Bader C Almonawer | 1 | 1 |
| YOUSHA C NEMAN-EBRAHIM | 1 | 1 |
| ISHWAR KANWAR PURI | 1 | 1 |
| PATRICK C WALTERS | 1 | 1 |
| ALAN C CHIANG | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.